Results
|
340441.
|
|
|
340442.
|
|
|
340443.
|
|
|
340444.
|
|
|
340445.
|
|
|
340446.
|
|
|
340447.
|
|
|
340448.
|
|
|
340449.
|
|
|
340450.
|
|
|
340451.
|
|
|
340452.
|
|
|
340453.
|
|
|
340454.
|
|
|
340455.
|
|
|
340456.
|
|
|
340457.
|
|
|
340458.
|
|
|
340459.
|
|
|
340460.
|
Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin. A prospective randomized controlled trial. [electronic resource] by
- Takaki, Shintaro
- Kawakami, Yoshiiku
- Imamura, Michio
- Aikata, Hiroshi
- Takahashi, Shoichi
- Ishihara, Hiroto
- Tsuji, Keiji
- Aimitsu, Shiomi
- Kawakami, Hiroiku
- Nakanishi, Toshio
- Kitamoto, Mikiya
- Moriya, Takashi
- Satoh, Kenichi
- Chayama, Kazuaki
Producer: 20080422
In:
Intervirology vol. 50
Availability: No items available.
|